A number of distinct simian immunodeficiency virus (SIV) isolates have been characterized. SIV ...... isolated from captive macaques, causes infection and disease in cynomolgus and rhesus macaques that resemble in many respects the clinical course of disease in patients infected with human immunodeficiency virus (HIV) (Letvin et al., 1985) . Therefore there has been considerable interest in using this simian system as a model in which to develop and test vaccination strategies that might ultimately be applicable to HIV.
Although a matter of continuing debate (Desrosiers, 1992) , it has been widely held that a successful HIV vaccine would most plausibly be subunit-based rather than whole virus-based, in view of the difficulty of ensuring the safety of inactivated or attenuated whole virus preparations; such a subunit strategy has been employed previously to create a successful hepatitis B virus vaccine (Valenzuela et al., 1982; McAleer et al., 1984) . Therefore a number of heterologous systems have been used to express HIV and SIV antigens, with the intention of creating candidate vaccines for either clinical trials or testing in the simian model. Among the expression systems used, incorporation of appropriate cDNA sequences into either vaccinia virus or adenovirus offers the possibility of a vaccine with the safety of a subunit approach combined with the advantages of a live vaccine. Adenovirus has a number of potential advantages as a vaccine vector. Many of the human serotypes are minimally pathogenic and several have been characterized in great detail at the molecular level (Horwitz, 1990a, b) . They normally infect via respiratory or intestinal epithelia, and so offer ease of delivery and the possibility of stimulating both mucosal immunity and a cytotoxic T cell response. Finally, oral dose adenovirus vaccines have been in use for many years and appear both safe and effective (Edmondson et al., 1966; Top et al., 1971) .
Interest in the immune response to HIV and SIV has centred upon the surface glycoproteins of these viruses as there is evidence that neutralizing antibody can be elicited with these antigens (Ho et al., 1988; Rusche et al., 1988) , and that responses to these antigens can protect animals against subsequent live virus challenge (Berman et al., 1990; Hu et al., 1992) . Adenovirus serotype 5 and 7 (Ad5, -7) recombinants expressing HIV-1 envelope glycoproteins have been described (Chanda et al., 1990; Dewar et al., 1990) , as have Ad4 and -7 recombinants expressing HIV-1 gag products (Vernon et al., 1991) . Recently, the isolation of an Ad5 recombinant expressing the envelope glycoproteins of SIV .... together with the regulatory protein, Rev, was reported (Cheng et al., 1992) . Earlier work suggested that a strong anti-core antigen (gag) response was a good prognostic indicator in HIV-positive individuals (de Wolf et al., 1988) , and in other virus systems, internal structural proteins have proved to be important targets for the cellular arm of the immune system (McMichael et al., 1986; Gotch et al., 1987) . We decided therefore to generate recombinant vaccine candidates based on the gag antigens of SIV.
Ad5 wild-type virus has a genome close to the maximum length that can be accommodated by its capsid. Therefore, to incorporate a piece of foreign DNA into the genome, space must be created by deleting Ad5 sequences. Most of the genome encodes functions which are essential for virus growth. However, the E3 region can be deleted without affecting growth in culture (Jones & Shenk, 1978; Thimmappaya et al., 1982) , and the Ela/Elb region, although essential, can be deleted since 0001-1797 © 1993 SGM an effective complementing cell line, 293 (Graham et al., 1977) , is available to rescue viruses which lack these functions. In this study, replication-defective recombinants with replacement of E 1 sequences were constructed in an Ad5d/309 background whilst the background for the replication-competent E3 insertions was Ad5hr404. d/309 is a variant of wild-type strain 300 having altered restriction sites and a partial deletion of E3 sequences (Jones & Shenk, 1979) . hr404 carries a point mutation in the E2A gene which gives the virus an extended host range for simian cells (Klessig & Grodzicker, 1979; Kruijer et al., 1981) and was provided by Dr D. Klessig.
SIV cDNA fragments were subcloned into each of two Ad5 shuttle vectors, pNL3C and p404SX ( Fig. 1 a) , for reconstruction of E1 and E3 replacement viruses respectively, pNL3C was provided by Dr R. Schneider (New York University, N.Y., U.S.A.). It contains the XhoI C fragment of Ad5 cloned between EcoRI and SalI sites of pML2, a deleted variant of pBR322 lacking sequences in the region 1140 to 2490, with sequences between SacII (354) and SmaI (1008) replaced by the Ad5 major-late promoter (MLP) and tripartite leader (TPL) cDNA sequences (positions relative to the left end of the Ad5 genome) creating a SaII cloning site at the 3' end of the TPL. Inserts in pNL3C at the SalI site, when reconstructed into virus, are expressed from the Ad5 MLP, a promoter which is activated in trans by the Ela protein, with processing at Elb sites downstream. The TPL sequence included in these transcripts has been shown to enhance mRNA translation (Logan & Shenk, 1984) . p404SX is a derivative of plasmid pFGdX1 (Haj-Ahmad & Graham, 1986) where the original insert of Ad5 DNA in pBR322 [BamHI 21562 to right end (modified to BamHI) 35938, with sequences XbaI 28592 to 30470 deleted] has been altered and extended by the replacement of pBR322 SalI to BamHI and Ad5 BamHI (21562) to XhoI (24796) with the SalI (16746) to XhoI (24796) fragment from hr404. After reconstruction into virus, sequences inserted into p404SX at the XbaI site are expressed from the Ad5 E3 promoter, and at late times post-infection from the endogenous Ad5 MLP (Tollefson et al., 1992) , with RNA processing occurring at E3 signals downstream of the insert.
SIV gag p55 and p27 cDNA fragments were cut from pNIBSC7 and pKA27 (Almond et al., 1990) respectively. These plasmids were isolated by Drs N. Almond and P. Kitchin and coworkers from the 32H isolate of SIV ..... 251 (Cranage et al., 1989) and were obtained from the MRC AIDS Directed Programme (ADP) Repository (NIBSC, South Mimms). The p55gag SmaI-HincII fragment contains the entire SIV gag sequence whereas the p27gag KpnI-EcoRI fragment encodes the p27 core protein with a 20 amino acid N-terminal extension derived from the p17 matrix protein and an initiation ~75 "(x~)9 (X) B"~C codon provided by a synthetic primer during PCR amplification. These fragments, rendered blunt-ended as required by repair with T4 DNA polymerase in the presence of all four dNTPs, were ligated to pNL3C, cut with SalI and BglII and end-filled, to create plasmids pE1-55 (p55 insert) and pE1-27 (p27 insert), and to p404SX, cut with XbaI and end-filled, to create plasmids pE3-55 and pE3-27. In each case, the correct insert orientation for expression from the relevant promoter was identified by appropriate restriction enzyme digestion.
Recombinant viruses 309p55 and 309p27 were derived from pE1-55 and pE1-27 by linearizing with EcoRI and transfecting each plasmid, together with the XbaI fragments of d/309, into 293 cells by calcium phosphate coprecipitation (Fig. l b) . Viable viruses, formed by overlap recombination in vivo (Ho et al., 1982) were 6 and 7) . Samples were analysed by denaturing PAGE using a 10 % acrylamide gel, the gel was fixed and treated with Amplify (Amersham) and exposed to Fuji RX film.
isolated as plaques 7 to 8 days post-transfection and plaque-purified twice, using restriction digestion of purified viral D N A as a screen. Similarly, virus 404p55 was isolated using ClaI-linearized pE3-55 and the EcoRI fragments of hr404 ( Fig. 1 c) . When the p27 insert was cloned into p404SX, an EcoRI site was recreated at the right end of the insert. The 404p27 genome was generated by isolating the p27-containing EcoRI fragment from this plasmid and ligating it in vitro to a population of EcoRI fragments from hr404 viral D N A which had been treated with calf intestinal alkaline phosphatase to prevent self-religation ( Fig. 1 d) . This ligated D N A was then transfected into 293 cells to generate plaques (Stow, 1981) which were screened as above. Stocks of each virus, grown in either 293 or HeLa cells, were titrated by plaque assay in 293 cells. Recombinant viruses were assessed for associated hazard according to A C G M guidelines prior to construction and handled under category 2 containment. To examine gag antigen expression from these viruses, 293 or HeLa cells, cultured in plus 10 % foetal bovine 6) . Lane 9 shows an immunoprecipitation with polyclonal SIV antiserum of an extract of 293 cells infected with 309p55 that was analysed as a marker for p55gag. Other details as in Fig. 2  legend. serum, were infected at a multiplicity of 10 p.f.u./cell and labelled 15 to 18 h post-infection with [aSS]methionine ( > 1000Ci/mmol, Amersham) at a concentration of 100 gCi/ml in lacking methionine, adding 0"5 ml to each 6 0 m m culture dish. Gag antigens were immunoprecipitated from labelled cell extracts, prepared in R I P A buffer (10 mN-Tris-HC1 pH 7-6, 150 mN-NaC1, 1% sodium deoxycholate, I % Triton X-100, 0.1% SDS) with PMSF added at 2 mM immediately before use. Gagreactive antibodies used were either monoclonal antibodies (MAbs) isolated by Dr K. Kent and obtained via the M R C A D P Reagent Repository, or heat-inactivated polyclonal antiserum from cynomolgus macaques immu nized with live SIV .... 251 32H, obtained from the same source. 309p27 and 309p55 in 293 cells expressed proteins of the expected size that were precipitated specifically by the anti-SIV antiserum (Fig. 2, lanes 2, 3 and 5 ) and were not expressed in control virus infections (lanes 1 and 4) , or precipitated by control antibody (lane 6). In a similar experiment, 404p27 and 404p55 viruses expressed the expected SIV proteins in HeLa cells (Fig. 3, lanes 4 and  8) . Expression of p55 and p27 from the defective recombinants 309p55 and 309p27 could not be detected in these non-complementing cells (data not shown). To examine whether expression of SIV gag proteins by the replication-competent recombinant viruses represented a significant proportion of total protein synthesis in infected cells, aliquots of labelled infected HeLa cell Fig. 3 (lane 2) , p27 was detectable against the background of cellular and Ad5 proteins, indicating that it was being synthesized as a minor but significant component in the infected cells. Previous observations showed that HIV-1 gag proteins can self-assemble and exit the cell in the absence of either retroviral genomic RNA or envelope proteins (Gheysen et al., 1989; Shioda & Shibuta, t990; Vernon et al., 1991) . The export of p55 to the culture medium of cells infected with 404p55 was therefore evaluated by Western blot analysis. Unlabelled extracts of cells or antigen from culture fluid, concentrated by precipitation with 4% polyethylene glycol, 0"5 M-NaC1 overnight at 4 °C, lowspeed centrifugation and resuspension in RIPA buffer, were immunoprecipitated with excess polyclonal antibody, samples analysed by SDS-PAGE and transferred to nitrocellulose (Hybond C, Amersham) (Towbin et al., 1979) . Filters were blocked with 5 % non-fat milk powder in PBS and probed with MAbs at room temperature for 3 h. Bound antibodies were visualized by binding biotincoupled second antibody and streptavidi~horseradish peroxidase complex followed by reaction with substrate (H202, 4-chloronaphthol). p55 was detected in the culture medium (Fig. 4, lane 2) in significant amounts, approximately 50 % of those seen in the intracellular fraction from the same culture (lane 1). This release was not due to c.p.e, of the virus as release was specific to one of two related forms of p55 produced by 404p55 (see below) and similar release was also seen following transfection of expression plasmids in transient assays (data not shown).
Most simian cell lines are only semi-permissive for growth of wild-type Ad5. The replicating recombinants 404p27 and 404p55 were built in a background containing a missense mutation conferring increased growth potential in simian cells to overcome this problem. 404p55 and 404p27 were tested for SIV antigen expression in the simian cell line BSC-1, cultured in GMEM plus 5 % fetal bovine serum, by radiolabelling and immunoprecipitation. Both viruses expressed antigens of the expected size and at significant levels (Fig. 5,  lanes 2 and 4) . These levels were comparable to those seen in HeLa cells infected in parallel (data not shown). This result demonstrates that these recombinant viruses, built in the hr404 background, are able to replicate effectively in BSC-1 cells. When BSC-1 cells were infected with the non-replicating recombinant 309p27 at high m.o.i., a very low level of expression was detected (lane 5), in contrast to results in HeLa cells where no expression from this virus has been seen.
Close examination of the SIV immunoreactive material detected in infections by the 404p55 virus revealed a doublet of species with similar M~ values (Fig. 3, lane  8; Fig. 5, lane 2) , both of which were directly reactive with anti-SIV antibody (Fig. 4, lane 1) , and of which the faster migrating component comigrated with p55 expressed by virus 309p55 in 293 cells (Fig. 3, lane 9) . The production of this second p55-related species, p55", specifically by 404p55 suggested that its expression was a consequence of the DNA construction employed to generate this virus. The junction between Ad5 E3 and the 5' end of the inserted p55 cDNA was therefore subcloned into M13 and sequenced using Sequenase (USB). This analysis showed that an E3 AUG codon, normally used to initiate synthesis of a 6"7K protein in the related virus Ad2 (Wilson-Rawls et al., 1990) , was fused in-frame with the p55 sequence, adding 17 codons to the p55 reading frame. Initiation at this AUG in the recombinant would add 2-2K to p55, in agreement with the observed size of p55". These observations suggest that translation of the hybrid E3-p55 mRNA produced by 404p55 initiates at two alternative AUG codons to yield two closely related p55 products. Comparison of the intra-and extracellular gag polypeptides from a 404p55-infected culture (Fig. 4) shows also that p55" is under-represented in extracellular material when compared with p55; this may reflect an effect of the altered N terminus of p55" on p55 posttranslational processing, e.g. myristylation, assembly or interaction with the plasma membrane as a prelude to export. Finally, comparison of 404p55 infections of HeLa and BSC-1 cells showed marked differences in the relative levels of p55 and p55"; although these were produced at very similar levels in BSC-1 cells, p55" synthesis was only 25 % of total gag expression in HeLa cells (data not shown).
In summary, we have isolated a series of Ad5-SIV recombinant viruses that express either the p55 or p27 gag polypeptides of SIV. Replication-competent recombinants were equally capable of expressing gag polypeptides in the simian cell line BSC-1 and in HeLa cells and a proportion of the p55gag polypeptide expressed was exported to the culture fluid of infected cells. These viruses should prove to be of value in the production of target cells for SIV gag-specific cytotoxic T cell assays; it is also appropriate to consider these viruses as candidate vaccine components, in combination with envelope protein or envelope expression systems, for testing in the simian AIDS model.
